Novo Nordisk said it's ending its collaboration due to concerns with Hims & Hers the company's sales and promotion of cheap ...

In a first round human trial slimmers in Sweden taking the new drug-currently known as ATR-258-found they burnt fat yet preserved muscle mass.

Hims & Hers stock plummeted around 30% in early trading Monday after Novo Nordisk announced it was ending a collaboration to ...

While Eli Lilly brushed off concerns about gastrointestinal side effects for oral weight loss candidate orforglipron, ...

Hims & Hers stock drops after Wegovy manufacturer ends deal to distribute weight loss drug - Hims & Hers had partnered with ...

Novo Nordisk's U.S.-listed shares fell more than 5% Monday after the drugmaker revealed the latest results for a new weight-loss treatment.

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 29.2% in the morning session after Novo Nordisk, the maker ...

A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...

Lower blood sugar and increased fat burning—without negatively affecting appetite or muscle mass. These are some of the most ...

Amanda Bynes is starting a weight loss journey and turning to Ozempic for help. In a video shared to her Instagram Stories on ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...